A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

Clinical trial NCT02125162 · COMPLETED

Trial details

NCT number: NCT02125162
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2014-04-01
Primary completion: 2014-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.